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Hemodynamic effects of enalapril on neonatal chronic partial ureteral
obstruction (CPUO). To evaluate the role of angiotensin II (ANG II) in
renal vasoconstriction due to ipsilateral CPUO, guinea pigs were
subjected to incomplete left ureteral stenosis within the first 48 hr of
life, and were given enalapril from the 14th day of life until study at 23
3 days or 8 weeks of age. Renal blood flow (RBF) was measured using
radioactive microspheres, and glomerular filtration rate (GFR) was
derived from inulin extraction. The number of perfused glomeruli per
kidney was determined following in vivo India ink perfusion. Enalapril
treatment resulted in an 83% rise in RBF of the obstructed kidney, from
2.58 0.26 to 4.73 0.48 mI/mm (P < 0.001), which was associated
with a 26% increase in number of perfused glomeruli (P < 0.01). Mean
GFR of the hydronephrotic kidney increased from 0.13 0.02 to 0.37
0.10 mI/mm (P < 0.05). Enalapril had no effect on intraureteral pressure
of the obstructed left kidney after 7 to 13 days of administration, and did
not affect renal mass or ureteral diameter after 6 weeks of treatment. It
is concluded that hemodynamic consequences of CPUO in the neonate
may be attenuated by ANG converting enzyme inhibition. The primary
effect of enalapril is most likely inhibition of intrarenal ANG II
formation.
Effets hémodynamiques de I'énalapril sur l'obstruction urétérale
chronique partielle (OUCP) néona*ale. Afin d'évaluer le role de l'angi-
otensine II (ANG II) sur la vasoconstriction rdnale dO a une OUCP
controlatérale, des cobayes ont été soumis a une sténose incomplete de
l'uretère gauche pendant les premieres 48 heures de leur vie, et ont recu
de l'Cnalapril fl partir du l4ème jour de vie jusqu'au moment de l'étude,
a l'Oge de 23 3 jours ou 8 semaines. Le flux sanguin renal (FSR) a étë
mesuré en utilisant des microsphéres radioactives, et Ia filtration
glomCrulaire (FG) a etC obtenue par la clearance de l'inuline. Le
nombre de glomérules perfusés par rein a Cté déterminC apres une
perfusion d'encre de chine in vivo. Le traitement par enalapril a
provoqué une augmentation de 83 % du FSR du rein obstrué, de 2,58
0,26 a 4,73 0,48 mI/mm (p < 0.001), qui Ctait associC avec une
augmentation de 26 % du nombre des gloméniles perfusés (p < 0,01).
La FG moyenne du rein hydronéphrotique a augmente de 0,13 0,02a
0,37 0,10 mllmin (p < 0,05). L'énalapril n'a eu aucun effet sur la
pression intra-urdtCrale du rein gauche obstruC aprCs 7—13 jours
d'administration et n'a pas affectC La masse rénale ou Ic diamCtre
urCtCral apres 6 semaines de traitement. Nous concluons que les
consequences hemodynamiques de l'OUCP chez le nouveau-nC peuv-
ent être attënuées par l'inhibition de l'enzyme de conversion de 1'ANG.
L'effet primaire de l'Cnalapril est trés probablement l'inhibition de la
formation intra-rénale de I'ANG II.
Although obstructive nephropathy is a major cause of renal
insufficiency in infancy and childhood [1], factors contributing
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to decreased renal function remain incompletely understood.
While most previous experimental studies have addressed
models of complete ureteral obstruction [2], partial urinary tract
obstruction is of greater clinical interest because it is more
prevalent and is potentially reversible. Furthermore, because
most lesions are congenital, renal damage occurs early in life, at
the time of most rapid structural and functional development.
We have therefore developed a model of unilateral chronic
partial ureteral obstruction (CPUO) in the neonatal guinea pig
[3, 4]. In this species, like the human, nephrogenesis is com-
plete at the time of birth, and functional and renal maturation
proceeds rapidly during the first four postnatal weeks [5, 6].
Following partial constriction of the left ureter within the first 2
days of life, 23-day-old guinea pigs develop marked vasocon-
striction of the ipsilateral kidney and an 80% decrease in
glomerular filtration rate (GFR) [3]. This is associated with 34%
fewer perfused glomeruli compared to the untouched contralat-
eral kidney [3].
Previous studies have implicated angiotensin II (ANG II) as a
mediator of vasoconstriction during or following relief of com-
plete urinary tract obstruction [7—10], but others have not
confirmed this [11—13]. To our knowledge, the only published
report of vasoactive substances in CPUO was performed in
adult rats with mild ureteral obstruction [14]. Because infusion
of prostaglandin synthesis inhibitors resulted in increased arte-
riolar resistances of obstructed kidneys, the authors postulated
the action of a vasoconstrictor such as ANG II [14]. Since renal
vascular resistance (RVR) is normally higher [15], and circulat-
ing ANG II levels are increased in early postnatal life [16],
hemodynamics may differ in the neonate. The present study
was therefore designed to investigate the role of ANG II in the
observed vasoconstriction of unilateral severe CPUO in the
neonatal guinea pig. In view of its superior activity and lack of
nephrotoxicity, the new ANG II converting enzyme inhibitor,
enalapril, was used as a probe to block endogenous ANG II
formation in animals with CPUO. To minimize artifactual
changes due to relief of intraureteral pressure, hemodynamic
measurements were made without release of the ureteral con-
striction. Changes in the hydronephrotic kidney due to enalapril
administration were compared with those in the contralateral
intact kidney, as well as with sham-operated animals receiving
enalapril.
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Methods
Fifty-seven Hartley guinea pigs (male:female ratio 1:1) were
anesthetized with halothane within the first 48 hr of life, and the
left ureter was exposed through a midline abdominal incision. A
2 mm length of sterilized polyethylene tubing (PESO, Clay
Adams, Parsippany, New Jersey, USA) was slit longitudinally
and placed around the distal one-third of the ureter, after which
the incision was sutured and coated with collodion. Animals
were returned to their mothers until weaning at 14 days, after
which they were fed standard guinea pig chow (No. 5025,
Purina, St Louis, Missouri, USA). From the 14th day until the
time of study at 21 to 27 days of age, tap water was supplied to
animals in individual cages, and the volume consumed was
measured each day. Each litter was divided equally into two
groups: the first group received tap water alone (control), while
enalapril maleate (MK-421, Merck, Sharp & Dohme, Rahway,
New Jersey, USA) was added to the drinking water of the other
group. The enalapril was mixed freshly each day to provide a
concentration of 0.2 mg/nil, Angiotensin converting enzyme
activity of enlapril in aqueous solution is not diminished after 48
hr (SWEET CS, personal communication).
Animals were fasted with free access to drinking water the
night before study. On the day of study, guinea pigs were
anesthetized with intraperitoneal sodium pentobarbital, 3
mg/l00 g body wt and placed on a thermostatically controlled
heating table to maintain rectal temperature at 39 0.5°C.
Tracheostomy was performed and a jugular vein was can-
nulated for infusion of 0.9% saline containing [3H]inulin (New
England Nuclear, Boston, Massachusetts, USA) in a concen-
tration of 10 pCiJml, at a rate of 0.3 mlllOO g body wt/hr. To
replace surgical fluid losses, the contralateral jugular vein was
cannulated for infusion of donor guinea pig plasma at a rate of
0.9 ml/hr. A polyethylene catheter was threaded down the right
carotid artery so that the tip lay at the aortic root. Mean arterial
pressure (MAP) was continuously recorded from this catheter
by means of a Statham 231D pressure transducer coupled to a
Hewlett-Packard 7754B recorder. In four animals receiving
enalapril, teprotide, 0.2 mg was infused intravenously to max-
imally inhibit converting enzyme activity.
The left kidney and ureter were exposed through an abdom-
inal incision, and were kept moist throughout the experiment by
covering them with saline-soaked cotton. External diameter of
the left ureter was measured halfway between kidney and
bladder using calipers, and intraureteral pressure was measured
proximal to the stenosis in 14 animals using an 8-l0-m
micropipette (containing 2 M NaC!) connected to a servo-nulling
apparatus. A polyethylene catheter was then inserted in the
abdominal aorta at the aortic bifurcation for collection of a
refer nce blood flow sample during microsphere injection.
Because urine flow rates from the obstructed kidney were
previously found to be too low to be accurately measured [31,
urine was not collected. However, urine collected distal to the
stenosis from animals prepared in identical fashion contained
significant [3H] activity in each case, demonstrating patency of
the ureter [3]. Blood samples (100 1d) were drawn from the
carotid artery catheter at the beginning of the experiment and
after a 1-hr equilibration period for measurement of hematocrit
in heparinized tubes. The left renal vein was carefully dissected
free of perirenal fat and a 27G needle was inserted between the
adrenal vein and renal hilum after ligation of the gonadal vein.
One-hundred d of blood was withdrawn from the renal vein
into a heparinized syringe at a rate of 0.1 mllmin, while a similar
sample was obtained simultaneously from the carotid artery
catheter for determination of inulin extraction. Blood was not
obtained from the right renal vein because its access was
prevented by the bulky viscera in this species. All blood
withdrawn was replaced with an equal volume of donor guinea
pig blood.
In each animal, 50 to 80 x io latex microspheres 14 1 pm
in diameter, labeled with 85Sr (3M, St. Paul, Minnesota, USA)
were suspended in 10% dextran and Polysorbate 80 by vigorous
agitation (Vortex Genie, Scientific Industries, Bohemia, New
York, USA) and ultrasonication (Bransonic 12, Branson Co.,
Shelton, Connecticut, USA). During withdrawal of a reference
blood sample from the abdominal aorta at 0.7 ml/min using a
precision withdrawal pump (Harvard Apparatus, Millis, Mas-
sachusetts, USA), the microspheres were injected into the
carotid catheter and flushed with 0.5 ml 0.9% saline. After
replacement of blood withdrawn with an equal volume of donor
blood and equilibration of MAP, ANG I (Sigma, St Louis,
Missouri, USA), 1 pg/kg body wt (approximately 0.2 g in 0.2
ml 0.9% NaCl) was infused intravenously in 16 animals. After
MAP had stabilized (2 to 3 mm), a second bolus of 50 to 80 X l0
14 m spheres (labeled with "1Ce) was injected during with-
drawal of a reference sample. In eight animals, ANG II (Sigma)
(1 ig/ml saline) was injected intravenously at 0.1 g/min, and a
second bolus of microspheres was injected after MAP had
equilibrated (2 to 4 mm). After replacement of blood with-
drawn, 1 ml India ink (Higgins No. 4465, Newark, New Jersey,
USA) was infused in the carotid catheter, followed by infusion
of saturated potassium chloride solution to sacrifice the animal.
Blood from renal vein and carotid artery was diluted in PCS
solubilizer (Amersham, Arlington Heights, Illinois, USA) and
radioactivity measured in a beta scintillation counter (Beckman
Instruments, Irvine, California, USA). Kidneys were removed,
drained, decapsulated, bisected, weighed, and fixed in 10%
formalin solution. Radioactivity of the reference blood samples
and kidneys was measured in a gamma scintillation counter
(Beckman Instruments). In 16 animals, one-half of the kidney
was digested in 25% hydrochloric acid and the number of
perfused glomeruli was counted as described previously [5].
Remaining kidney tissue was weighed before and after drying at
40°C for 10 days for calculation of dry/wet ratio.
To evaluate the long-term effects of CPUO and enalapril
administration on somatic and renal growth, ten additional
guinea pigs (five receiving water, and five receiving enalapril)
were sacrificed at 8 weeks of age, and body wt, kidney wts, and
ureteral diameter were measured. To assess the effects of
chronic enalapril administration on normal growth and renal
function, 11 sham-operated guinea pigs were given enalapril in
the drinking water starting at 14 days of age, and were studied
at 22 to 26 days of age.
Calculations
Filtration fraction was given by the renal inulin extraction
ratio. Cardiac output, total vascular resistance (TVR), RBF,
and RVR were calculated from microsphere data and GFR was
calculated from RBF and inulin extraction ratio as described
previously [3, 17].
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Table 1. Characteristics of guinea pigs with partial left ureteral obstruction
Age
days
Birth
wt
Body
wt
L kidney
wt
R kidney
wt Water
intake
mi/day
Hct,
pre
%
Hct,
post
%
L ureter
diameter
mm
Lureter
pressure
mm Hg
L kidney
FF
%
•L kidney
GFR
mi/mmg
Water 23.2 106.0 213.8 l.07 1.53 37.3 41.3a 39.1 4.3 6.6 10,6 0.13
SE 0.3 2.9 6.8 0.03 0.07 1.7 0.4 0.8 0.1 0.9 2.0 0.02
N 23 22 23 23 23 23 21 21 22 7 11 11
Enalapril 23.5 101.6 204.9 l.l3 1.37 34.8 38.0 38.0 4,2 5.9 11.2 0.37
SE 0.4 2.6 7.6 0.04 0.05 1.6 0.4 0.5 0.1 0.6 1.9 0.10
N 24 23 24 24 23 24 23 23 22 7 12 12
P NS NS NS NS NS NS <0.001 NS NS NS NS <0.05
Abbreviations are: L, left; R, right; Hct, hematocrit on day of physiologic study; pre, beginning experiment; post, end of experiment; FF,
filtration fraction; GFR, glomerular filtration rate; SE, standard error; N, number of animals; NS, not signficant.
a P < 0.01.
Table 2. Characteristics of 8-week-old guinea pigs with left partial
ureteral obstruction
Age
days
Body
wt
L kidney
wt
R kidney, L ureter
diameter
mmg
Water 57.8 402.4 1.09 2.35 5.0
SE 0.8 30.1 0.18 0.14 0.3
N 5 5 5 5 5
Enalapril 58.4 384.4 1.05 2.34 4.8
SE 1.0 27.6 0.16 0.11 0.2
N 5 5 5 5 5
Statistical analysis
The effects of enalapril, age, and CPUO of morphometricand
hemodynamic measurements were evaluated by means of the
Student's t test for unpaired data. Comparisons between left
and right kidneys were made using Student's t test for paired
data. The effects of CPUO and enalapril on number of perfused
glomeruli, shown in Figure 4, were evaluated for each kidney
by one-way analysis of variance. Statistical significance was
defined as P < 0.05.
Results
As shown in Tables 1 and 2, there was no difference in
somatic growth as a result of chronic enalapril administration,
even after 8 weeks of age. Body wt of sham-operated animals
(Table 3) was not different from that of guinea pigs with CPUO
receiving enalapril (Table 1). Wet kidney wt was unaffected by
enalapril administration, and mass of the obstructed left kidney
did not change from 3 to 8 weeks of age (Tables 1 and 2). In each
case, the left kidney surface was irregular, with dilatation of the
renal pelvis, and the left ureter was uniformly distended and
tortuous to the point of obstruction. Mass of the unobstructed
right kidney was significantly greater than the left, and in-
creased more than 50% from 3 to 8 weeks of age (Tables 1 and
2). Compared to animals with CPUO receiving enalapril (Table
1), left kidney wt of sham-operated guinea pigs was not dif-
ferent, while that of the right kidney was less (P < 0.001) (Table
3). The ratio of dry/wet kidney wt for 3-week-old animals
receiving water was 0.178 0.004 and 0.204 0.004 fo; left and
right kidneys, respectively (N = 10). This did not differ from the
ratio for animals receiving enalapril, which averaged 0.188
0.003 and 0.213 0.004 for left and right kidneys (N = 9). In
each group, the ratio for the right kidney was greater than for
the left (P < 0.001). Diameter of the left ureter in guinea pigs
with CPUO was greater than that of the normal right ureter,
(which remained 1.0 0.0 mm) and increased further from 3 to
8 weeks of age (P < 0.025) (Tables 1 and 2). There was no effect
of enalapnl on intraureteral hydrostatic pressure (Table 1).
Daily water intake was unaffected by CPUO or enalapril
administration (Tables 1 and 3). The daily enalapril dose was 7.0
0.3 mg for animals with CPUO, and 6.7 0.3 mg for
sham-operated guinea pigs studied at 23 days of age. This
amounted to approximately 30 mg/kg/day. Hematocrit at the
beginning of the experiment on the day of study was lower in
animals receiving enalapril than in control littermates (Tables 1
and 3), and decreased by 2 volumes % during the experiment in
controls (P < 0.01), but did not change in those receiving
enalapril (Table 1).
As shown in Table 4, enalapril administration resulted in a
17% decrease in MAP. Infusion of a bolus of ANG I resulted in
a rise of MAP to 88.6 2.0mm Hg in the group receiving water,
and to 66.6 2.0 mm Hg in the animals reciving enalapril (P <
0.001). Increment in MAP due to ANG I infusion was not
correlated with RBF of the left kidney in animals with CPUO
receiving enalapril (r2 = 0.05, P = NS). Infusion of ANG II
caused a similar increase in MAP in both groups: resultant MAP
was 82.8 2.5 mm Hg and 78.4 2.4 mm Hg for water and
enalapril groups, respectively (P = NS). Four animals receiving
teprotide in addition to enalapril showed no difference in left
kidney blood flow (Fig. 1), and results were therefore combined
with those receiving enalapril only. As shown in Table 4,
enalapril administration had no significant effect on cardiac
output or right kidney RBF, but mean RBF of the obstructed
left kidney increased 83% from 2.58 to 4.73 mllmin. As shown
in Figure 1, left kidney RBF was not increased in all animals
receiving converting enzyme inhibitor, but there was no rela-
tionship between RBF and duration of enalapril administration.
Mean left kidney RBF of animals with CPUO receiving
enalapril was not different from that of sham-operated animals
treated with the drug, while right kidney RBF was 71% higher
(P < 0.005) (Tables 3 and 4). As shown in Figure 2, ANG I and
II decreased RBF of both kidneys in control animals with
CPUO by approximately 50%, and resulting RBF was not
different after ANG I and II. For animals receiving enalapril,
RBF of left and right kidneys following ANG II infusion was
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Table 3. Data for sham-operated guinea pigs receiving chronic enalapril
Age
days
Body wt L kidney wt R kidney wt
Water intake Hct, pre Het, post L
g mi/day % %
•
ureter diameter
mm
Mean 23.7 220.7 1.16 1.10 33.6 38.6 37.1 1.0
SE 0.3 7.9 0.05 0.04 1.7 0.9 0.8 0.0
N 11 11 11 11 11 9 9 11
MAP
mm Hg
Cardiac output L kidney RBF R kidney RBF TVR L kidney RVR R kidney RVR
mI/mm mm Hg/m1 mm
Mean 50.9 94.8 5,74 5.81 0.60 9.26 9.79
SE 2.9 14.7 0.76 0.86 0.09 0.85 1.37
N 11 7 9 9 7 9 9
Table 4. Hemodynamic measurements of guinea pigs with partial left ureteral obstruction
MAP
mm Hg
Cardiac L kidney R kidney L kidney R kidney
output RBF RBF TVR RYR RVR L RVRITVR
mi/mm mm Hg/mi mm
R RVR]TVR
Water 66.7 81.4 2.58 7.96 1.02 31.7 9.7 33.6 10.2
SE 1.5 9.4 0.26 0.68 0.13 4.2 1.2 3.9 0.8
N 23 18 19 19 18 19 19 18 18
Enalapril 55.4 95.5 4.73 9.93 0.61 13.4 5.9 22.8 10.2
SE 1.6 8.7 0.48 0.91 0.05 1.4 0.5 2.2 0.8
N 24 20 20 20 20 20 20 20 20
P <0.001 NS <0.001 NS <0.01 <0.001 <0.01 <0.025 NS
Additional abbreviations: MAP, mean arterial pressure; RBF, renal blood flow; TVR, total vascular resistance; RVR, renal vascular resistance.
more than 50% lower than RBF of respective kidneys following
ANG I, but the difference was of borderline significance (0.05 <
P < 0.1)
Total vascular resistance and right kidney RVR were reduced
by 40% as a result of enalapril treatment (Table 4). However,
RVR of the obstructed left kidney was reduced by 60%. The
ratio of left kidney RVR to total vascular resistance therefore
deceased from 33.6 3.9 to 22.8 2.2 (P < 0.025) due to
enalapril, while the ratio for the right kidney remained un-
changed at 10.2 0.8. Thus, while enalapril decreased resist-
ance in all vascular beds, the effect on the obstructed left kidney
was significantly greater. Compared to sham-operated guinea
pigs receiving enalapril, left kidney RVR was higher in animals
with CPUO receiving enalapril (P < 0.025), while resistance of
the right kidney was lower in those with contralateral obstruc-
tion (P < 0.005) (Tables 3 and 4). As shown in Figure 3, ANG
I and II had a similar effect on left and right RYR in animals
receiving water, while RVR was more than twofold greater
following ANG II than ANG I in the group receiving enalapril
(P < 0.025). There was no significant difference in the ratio of
left to right kidney RVR before or after ANG I or ANG II for
either group. Thus CPUO caused no difference in vasoconstric-
tor response to similar pharmacologic doses of ANG I or ANG
II.
The number of glomeruli containing identifiable India ink in
each kidney is shown in Figure 4. Included for comparison are
data from sham-operated animals receiving ordinary drinking
water, reported previously [3]. There was no difference be-
tween number of perfused glomeruli in left compared to right
kidneys except for the group with CPUO not receiving drug. In
animals with CPUO compared to sham-operated controls, there
was no difference in number of perfused glomeruli in the left
obstructed kidney, while the number in the contralateral right
kidney increased by 33%. Enalapril treatment had the effect of
increasing the number of perfused glomeruli of both kidneys in
sham-operated animals, and of the left kidney in animals with
CPUO. There was no further increase in number of perfused
glomeruli of the unobstructed right kidney in guinea pigs with
left CPUO receiving enalapril.
Filtration fraction for the obstructed kidney was not affected
by enalapril, but mean GFR was significantly increased as a
result of enalapril administration (Table 1). As shown in Figure
5, RBF of the obstructed kidney was not increased in all
animals receiving enalapril. However, GFR was elevated in all
those with RBF greater than 5 mllmin. In control animals, GFR
did not change over the measured range of RBF (Ito 5 mllmin).
Discussion
The major finding of this study is that chronic enalapril
administration results in significant vasodilation of the neonatal
guinea pig kidney subjected to CPUO. This is associated with a
26% increase in number of perfused glomeruli identified by
India ink. It is likely that the observed effects of enalapnl on
renal hemodynamics are largely due to inhibition of conversion
of ANG I to ANG II [18, 19]. Compared to captopril, which
contains a sullhydryl group, enalapril has a greater absolute
affinity for ANG converting enzyme [20]. However, additional
effects must also be considered. By stimulating arachidonic acid
release, captopril may stimulate prostaglandin synthesis [21],
but enalapril does not share in this effect [22]. Because ANG
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Enalapril treatment, days
Fig. 1. Relationship of renal blood flow to days of enalapril treatment
for left hydronephrotic kidney of 23 3-day-old guinea pigs. Each point
represents one animal. denote animals receiving enalapril alone, and
+ indicate animals also receiving teprotide. There was no significant
correlation between renal blood flow and days of enalapril treatment (r2
= 0.11).
converting enzyme cleaves vasodilator kinins to inactive frag-
ments, converting enzyme inhibitors may also increase circu-
lating kinin levels [23]. Although potentiation of kinins may be
significant in vascular beds other than the kidney [24], some
observations of circulating kinins may have been subject to
experimental artifact [191, and enalapril does not appear to have
any consistent effect on plasma bradykinin levels [22]. Further-
more, Yarger, Schocken, and Harris [8] have shown that
captopril increased inulin and para-aminohippuric acid clear-
ance in the rat kidney after release of 24 hr complete ureteral
obstruction, an effect which was not diminished by administra-
tion of agents known to inhibit kinin synthesis or to degrade
kinins. Taken together, the bulk of current evidence thus favors
a primary role of converting enzyme inhibition on ANG II
formation.
The lower initial hematocrit of enalapril-treated compared to
control animals with CPUO may have been due to slight volume
expansion in the former group, resulting from sodium retention
secondary to prolonged vasodilatation with enalapril. However,
hematocrit was not different at the time of microsphere injec-
tions, and increase of RBF by converting enzyme inhibition has
been shown in salt-loaded or -depleted animals [18]. It is
therefore unlikely that the observed variation in RBF was due
to differences in volume status of the animals.
Persistence of a vasopressor response to ANG I following
enalapril (and teprotide) administration in the neonatal guinea
pig suggests incomplete converting enzyme inhibition. How-
ever, it appears that ANG II formation may be effectively
suppressed regardless of the depressor response, which is less
specific [18]. While not all guinea pigs receiving enalapril
demonstrated a significant increase in RBF of the obstructed
kidney compared to controls, this could not be correlated with
a lack of a depressor response to ANG I in these animals.
Furthermore, there was no correlation of the number of days of
enalapril administration with left kidney blood flow. The van-
ability in response to enalapril may therefore result from
vasoconstnictors acting independently from ANG II.
Because enalapnil was administered systemically to the
guinea pigs in the present study, both intrarenal and extrarenal
converting enzyme were inhibited. Since there was no differ-
ence in RVR following ANG II compared to ANG I in control
animals with CPUO, it is unlikely that the observed vasocon-
striction of the obstructed kidney in animals receiving water
was due to increased intrarenal converting enzyme activity.
This observation is in agreement with Zimmerman et al [25],
who found that intrarenal converting enzyme plays a minor role
in the renal vasodilator response to captopril and teprotide.
However, it has been shown that intrarenal ANG I conversion
is approximately 22% in a single pass through the kidney of the
anesthetized dog, and is independent of RBF [26, 27]. Since
enalapril decreased RVR of the obstructed kidney more than
that of the contralateral kidney or resistance of other vascular
beds, ureteral obstruction resulted in specific intrarenal effects
in addition to any systemic alterations in the renin-angiotensin
system. Recent studies indicate that locally produced ANG II
contributes significantly to regional vascular tone [28, 29].
Possibilities include increased renin release, decreased degra-
dation of ANG II by the obstructed kidney, or increased
sensitivity to ANG II (increased ANG II receptor number or
binding affinity). Increased "pressor material" has been iden-
tified in the kidney subjected to prolonged ureteral ligation [30],
and the juxtaglomerular granulation index of both obstructed
and contralateral unobstructed kidneys was found to be in-
creased 7 and 14 days following unilateral ureteral ligation [31].
However, kidneys of animals with congenital bilateral hydro-
nephrosis were found to have decreased renin content [32]. It
is, therefore, difficult to predict which mechanism is responsible
for ANG Il-mediated vasoconstriction in CPUO, although the
response may be localized to a single obstructed nephron [10].
While the present experiments do not permit localization of
the site of vasoconstriction within the obstructed kidney, an
increase in number of glomeruli containing India ink following
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Fig. 2. Renal blood flow for left (L) hydronephrotic and right (R)
unoperated kidney of guinea pigs receiving ANG I or ANG II intrave-
nously. Symbols are: , pre ANG 1; , post ANG I; , preANG H; ,
post ANG II. For each group (water and enalapril), eight animals
received ANG I and four received ANG II. Values are mean SE.
L kidney R kidney L kidney R kidney
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Sham
Enalapril
Fig. 4. Number of perfused glomeruli in left () or right () kidney in
each group. Data for sham-operated animals not receiving enalapril are
from [31. Number of animals in each group: sham, 8; sham-enalapril, 6;
CPUO, 9; CPUO-enalapril, 7. *p <0.01 vs. same kidney of animals in
sham group not receiving enalapril. < 0.01 left vs. right kidney.
enalapril administration suggests that nephron response is het-
erogeneous. India ink has been used to estimate glomerular
perfusion in a number of previous studies of functional renal
development and response to renal injury [33—361. Although
absence of detectable India ink cannot be interpreted as a total
lack of blood flow to a glomerulus, it is reasonable to conclude
a significant qualitative difference in perfusion between
glomeruli containing and lacking identifiable carbon particles. It
is unlikely that India ink would significantly alter the rheologic
properties of blood flow to the kidneys, because the amount
injected represents only 5% of the blood volume. Since con-
verting enzyme inhibition increased total number of perfused
glomeruli of both kidneys of normal animals, it is likely that the
previously described maturational increase in number of
perfused glomeruli in this species [5] is controlled or modulated
by ANG II. Although it is possible that higher levels of
circulating ANG II present in early postnatal development [161
may contribute to reduced glomerular perfusion in the normal
or hydronephrotic kidney, the accelerated increase in number
% ofperfused glomeruli of the hypertrophic contralateral kidney/) demonstrates the importance of intrarenal factors in the re-
sponse to ANG II. Hornych, Beaufils, and Richet [37] have
7/) demonstrated previously heterogeneous glomerular
/> vasoconstrictor response to exogenous ANG II in the rat, and
others have shown unevenly distributed preglomerular resist-
ance [381 and single nephron GFR [39] after release of unilateral
ureteral obstruction. Undetectable perfusion of 26% of
/,/' \ glomeruli in the obstructed guinea pig kidney is also consistent
with patchy preglomerular vasoconstriction. Although ANG II
cuo appears to act preferentially on the efferent glomerular arteriole
EnalaprU [40], afferent arteriolar constriction may also develop when
systemic or locally formed ANG II levels are increased [41].
Because enalapril administration had no effect on filtration
fraction of the obstructed kidney, GFR increased significantly
in animals with elevated RBF due to converting enzyme inhi-
bition. Although it is possible that filtration fraction was under-
estimated in obstructed kidneys due to tubular inulin leakage
[42], it is unlikely that enalapril significantly altered tubular
permeability to inulin. If by reducing endogenous ANG II
formation, enalapnl decreased efferent glomerular artenolar
resistance, this effect was masked by afferent arteriolar dilation
[41] and/or increased ultrafiltration coefficient [43]. An effect of
enalapril on the latter is likely because ultrafiltration coefficient
is reduced in rats with mild CPUO [14] and in neonatal guinea
pigs with CPUO and contralateral nephrectomy [4].
Despite reduction in MAP due to systemic vasodilation,
enalapril administration had no effect on somatic or renal
growth up to 8 weeks of age (which represents adulthood in this
species). While the obstructed left kidney did not increase in
weight after 3 weeks of age, the left ureter continued to dilate,
and the right kidney underwent progressive compensatory
hypertrophy. Furthermore, there was no effect of converting
enzyme inhibition on the severity of hydronephrosis as mea-
sured by ureteral diameter and intraureteral hydrostatic Dres-
Water Enalapril
+
f
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>
Fig. 3. Renal vascular resistance (RVR)for each kidney of guinea pigs
in Figure 2 receiving ANG I or ANG II intravenously. Symbols same as
Figure 2.
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sure. This is remarkable in view of the significant increase in
RBF and GFR of the obstructed kidney in animals receiving
enalapril, and indicates that impairment of renal function due to
CPUO may be reversible despite growth arrest of the kidney. In
adult rats subjected to temporary complete unilateral ureteral
obstruction and studied 3 months after relief of obstruction,
chronic captopril administration resulted in enhanced renal
growth as well as improved inulin and para-aminohippurate
clearances [9]. It is possible that following release of CPUO,
growth of the neonatal kidney would also be promoted by
converting enzyme inhibition.
In summary, prolonged ANG converting enzyme inhibition
with enalapril selectively increased blood flow to the neonatal
kidney with ipsilateral CPUO. Nephron perfusion response to
converting enzyme inhibition was heterogeneous, evidenced by
an increase in number of glomeruli containing India ink injected
in vivo. Glomerular filtration rate of the obstructed kidney was
increased in those animals with increased RBF. Despite these
hemodynamic effects, the obstructed kidney failed to show
enhanced growth, and severity of hydronephrosis was unal-
tered even after 6 weeks of enalapril treatment. It appears that
in the neonatal guinea pig, the proportion of perfused glomeruli
in each kidney is modulated by activity of the renin-angiotensin
system, as well as by the stimulus of compensatory renal
hypertrophy [3, 5]. The marked differences in hemodynamic
adaptation of left and right kidneys of animals with unilateral
CPUO indicates that the intrarenal milieu is of greater impor-
tance than the influence of circulating factors. Although these
observations suggest strongly that locally formed ANG II
contributes to vasoconstriction in unilateral CPUO of the
neonate, additional vasoconstrictors, such as thromboxanes,
may also be involved.
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